RS102895 HCl是一种强效 CCR2 拮抗剂，IC50 为 360 nM，对 CCR1 无影响。

NSC 5844 is a bisquinoline compound with C-C chemokine receptor type 1 (CCR1)-agonistic properties.

CR2 antagonist 4 是一种有效且特异的 CCR2 拮抗剂，对 CCR2b 的 IC50 为 180 nM。它对 MCP-1 诱导的趋化性表现出强抑制作用，IC50 为 24 nM。

IPG7236是一种选择性CCR8拮抗剂。IPG7236在人乳腺癌小鼠异种移植模型中显示出显著的肿瘤抑制作用，可用于癌症研究。

Bindarit, a CCL2, CCL7 and CCL8 inhibitor, is an anti-inflammatory agent.

DAPTA is a potent and selective CCR5 antagonist.

Potent and selective CCR3 antagonist

PF-4136309 is a potent, Selective, and orally bioavailable CCR2 antagonist.

PF-4136309 is an orally available CCR2 antagonist with potential immunomodulating and antineoplastic activities.

AZD2098 is a potent CC-chemokine receptor 4 (CCR4) inhibitor, used for asthma research.

C 021 2HCl is a potent CCR4 chemokine receptor antagonist.

ZK756326 is a full agonist of CCR8（Chemokine receptor 8） with an IC50 of 1.8 μM, dose-responsively eliciting an increase in intracellular calcium and cross-desensitizing the response of the receptor to CCL1.

BX471 HCl is a potent, selective non-peptide CCR1 antagonist (Ki = 1 nM for human CCR1) and exhibits 250-fold selectivity for CCR1 over CCR2, CCR5 and CXCR4.

RS 504393 is a selective CCR2 chemokine receptor antagonist (IC50 values are 98 nM and > 100 μM for inhibition of human recombinant CCR2b and CCR1 receptors respectively).